Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Results for Quarter ending Sep 30, 2026.

8> CONCORD DRUGS LIMITED CIN No. : L24230TG1995PL.C020093 Regd. Office & Factory : Survey No. 249, Brahmanapally Village, Hayathnagar Mandal, R.R. Dist. - 501 511. (T.S) INDIA. E-mail : concorddrugsltd@gmail.com Ph.No : +91 8052779505 Wehsite - www concorddrgs in Date: 05.11.2026 BSE Limited PJ Towers Dalal Street, Fort Mumbai — 400001 Scrip Code: 538965 ISIN: INE858L01010 Subject: Intimation of Board Meeting. Ref: Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of Concord Drugs Limited is scheduled to be held on Thursday, 12th November, 2026 at the Registered office of the company inter alia to consider and approve the Un-audited (Standalone & Consolidated) financial results of the company for the Quarter ended 30th Sep,2026 and to transact such other business as may be considered necessary with the permission of the Chair. Further, in accordance with the Company’s Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the Company’s equity shares has been closed for all designated persons and their immediate relatives, and shall remain closed till 48 hours after the declaration of the said financial results. Kindly take this intimation on your record. For Concord Drugs Limited (S. Manoj Kumar Reddy) (DIN: 06991382) Whole Time Director